Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;33(1):97-105.
doi: 10.1007/s12288-016-0661-3. Epub 2016 Feb 22.

Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases

Anil Tombak  1 , Mehmet Ali Uçar  1 , Aydan Akdeniz  1 , Arda Yilmaz  2 , Hakan Kaleagası  2 , Mehmet Ali Sungur  3 , Eyup Naci Tiftik  1
Affiliations

Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases

Anil Tombak et al. Indian J Hematol Blood Transfus. 2017 Mar.

Abstract

Therapeutic plasma exchange (TPE) is a procedure that reduces circulating autoantibodies of the patients. TPE is commonly used in neurological disorders where autoimmunity plays a major role. We report our experience with regard to the indications, adverse events and outcomes of plasma exchange in neurological disorders. Sixty-three patients were included to this retrospective study. Median age was 48 years (range 1-85), there was a predominance of males. Neurological indications included Guillain-Barrè syndrome (n = 22), myasthenia gravis (n = 21), chronic inflammatory demyelinating polyneuropathy (n = 7), polymyositis (n = 3), multifocal motor neuropathy (n = 2), acute disseminated encephalomyelitis (n = 2), neuromyelitis optica (n = 2), multiple sclerosis (n = 2), limbic encephalitis (n = 1) and transverse myelitis (n = 1). TPE was frontline therapy in 57 % of the patients (n = 36). Total number of TPE sessions was 517; median number of sessions per patient was 8 (range 1-66). TPE was done through a central venous access in 97 % and through a peripheral venous access in 3 % of the patients. Human albumin was used as replacement fluid in 49 %, hydroxyethyl starch (HES) in 49 % and fresh frozen plasma in 2 % of the cases. Adverse reactions were recorded in 60 % of the patients. Total ratio of complications in 517 TPE procedures was 10.8 % and these were mild and manageable such as allergic reactions and hypotension. Overall response rate was 81 %. Interestingly, complication and response rates were similar in both HES and human albumin groups. We conclude that TPE is an effective treatment in neurologic diseases in which autoimmunity plays an important role in the pathogenesis and HES can be used instead of albumin as replacement fluid in these disorders, since it is cost-effective, has similar efficacy and complication rates.

Keywords: Demyelinating disease; Guillain-Barrè syndrome; Myasthenia gravis; Polyneuropathy; Therapeutic plasma exchange.

PubMed Disclaimer

References

    1. Weinstein R. Therapeutic apheresis in neurological disorders. J Clin Apheresis. 2000;15:74–128. doi: 10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O. - DOI - PubMed
    1. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian apheresis study group. N Engl J Med. 1991;325:393–397. doi: 10.1056/NEJM199108083250604. - DOI - PubMed
    1. Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL. The new approach to assignment of ASFA categories—introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher. 2007;22:96–105. doi: 10.1002/jca.20134. - DOI - PubMed
    1. Pinching AJ, Peters DK, Newsom-Davis J. Remission of myasthenia gravis following plasma exchange. Lancet. 1976;308:1373–1376. doi: 10.1016/S0140-6736(76)91917-6. - DOI - PubMed
    1. Yeh J-H, Chiu H-C. Plasmapheresis in myasthenia gravis. Acta Neurol Scand. 1999;99:147–151. doi: 10.1111/j.1600-0404.1999.tb07336.x. - DOI - PubMed

LinkOut - more resources